South Carolina Research Authority’s investment affiliate, SC Launch Inc., has invested in MitoChem Therapeutics. The $200,000 investment will help the startup continue developing solutions that show promise in the treatment of several eye disorders.
MitoChem Therapeutics became an SCRA Member Company in 2019 and received a $25,000 Academic Startup Grant. It became an SC Launch Inc. Portfolio Company with this investment. MitoChem has also been a long-term tenant at SCRA’s Innovation Center in Charleston. Read more.
|